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A B S T R A C T
Background: Lymphoma is the third most common pediatric malignancy. The purpose of this study was
to analyze the incidence rates of lymphoma in children and adolescents in Brazil.
Methods: All cases of Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), and Burkitt lymphoma
(BL) were extracted from 14 population-based cancer registries (PBCRs) from 2000 to 2005, and included
children and adolescents 0–19 years old. Analyses included age-adjusted incidence rates (AAIRs) and
age-speciﬁc incidence rates (ASIRs) by each PBCR. A social exclusion index (SEI) was built and used as
proxy for socioeconomic status (SES) levels. Correlations between SES and incidence rates were
investigated using Spearman’s test.
Results: The median incidence of lymphoma was 22.7/million. AAIRs of lymphomas varied from 12.9
(Salvador) to 34.5 per million (Sa˜o Paulo). Median AAIR was 8.8/million, 9.8/million, and 2.9/million for
NHL, HL, and BL, respectively. In all PBCRs except that of Recife, AAIR was slightly higher in males than
females. The median ASIR was highest for HL (18.5/million) at 15–19 years for both genders. For NHL
there were two peaks for ASIR: 11.1/million (1–4 years of age) and 13.2/million (15–19 years of age). The
median ASIR for BL was highest among children aged 1–4 years (4.7/million) and in males. Higher SEI
correlated with higher incidence of HL (P = 0.06), whereas rates of NHL and BL did not correlate with SEI.
Borderline different incidence rates were observed in HL correlated with cities with higher SEIs.
Conclusion: Incidence rates of lymphomas in Brazil do not differ compared to rates reported worldwide,
although SES differences deserve further investigation.
 2012 Elsevier Ltd. 
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Lymphoma in children and adolescents comprises a heteroge-
neous group of malignant diseases of lymphoid tissues. The various
lymphoma diagnoses present with distinctive biological and
epidemiological features; it is therefore recommended that they
are investigated separately. There are substantial variations
worldwide in the incidence of childhood malignancies, among
which lymphomas are a dominant type [1].
In developed countries, lymphoma is the third most common
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Open access under the Elsevier OA license.1.5–2.0-fold male predominance in all ages for non-Hodgkin
lymphoma (NHL). Both Hodgkin lymphoma (HL) and NHL are
rarely diagnosed in children younger than 5 years. Among NHLs,
age-speciﬁc incidence varies according to histological subtype.
Burkitt’s lymphoma (BL) occurs in children between the ages of 5
and 15 years, whereas NHL, mainly lymphoblastic, occurs more
commonly in older children and adolescents. HL is more common
in children older than 10 years, making the incidence almost twice
that of NHL in children between the ages of 15 and 19 years [2].
Data on the incidence of childhood NHL need to be explored,
particularly in less developed countries [3]. Temporal studies from
the United States and the Manchester Children’s Tumour Registry
in the United Kingdom report that the childhood incidence rate of
NHL has been relatively stable [1,4,5].
Data regarding the incidence of lymphoma in less developed
nations are scarce. In Africa, lymphomas account for almost one
half of childhood cancers, with the majority being BL [6]. In Brazil, a
recent population-based study demonstrated that lymphoma
Fig. 1. The percentage ratio distribution of lymphoma subtypes in Brazil, 2000–2005.
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These data led us to analyze the lymphoma incidence rates (HD,
NHL, and BL) in children and adolescents (<19 years) and to
evaluate their correlation with socioeconomic status (SES) in
Brazil.
2. Materials and methods
2.1. Study population
Cases were extracted from the databases of 14 population-
based cancer registries (PBCRs) located in 14 major Brazilian cities
(Fig. 1, supplementary). Databases contain the period and
population coverage for each PBCR, as well as the social exclusion
index (SEI). The incidence rates of lymphoma in children and
adolescents <19 years of age were collected for the period 2000–
2005. Data from all PBCRs included were reviewed from data entry
to selection of eligible cases according to a consistency checklist.
The variables evaluated were compatibility between anatomical
site and gender, anatomical site and morphology, morphology and
extension of the disease, date of birth and date of diagnosis, tumor
site and age, morphology and age, date of death (if it occurred),
date of birth, and date of diagnosis. To avoid mismatches between
cases and population at risk, a double check was performed by
automated record linkage, comparing case ascertainment accord-
ing to home address (included only in the covered area), mothers’
names and children’s date of birth, gender, and disease character-
istics. Then a second data check was performed manually [7]. Case
deﬁnitions with conﬁrmed diagnosis of cancer were assigned a
morphology and topography code as per the International
Classiﬁcations of Disease for Oncology 2nd edition (ICD-O2) [2]
2000–2004 and ICD-O3 [8] 2005. The different types of lymphoma
were then grouped according to the International Classiﬁcation of
Childhood Cancer (ICCC) [9]. Lymphoma was subdivided into three
major groups for the analysis: HL, NHL and BL. In the NHL group the
following categories were included: NHL (II.b), the miscellaneous
lymphoreticular neoplasms (II.d), and unspeciﬁed lymphoma (II.e)
according to the ICCC. The underlying population at risk for each
region was obtained from the Instituto Brasileiro de Geograﬁa e
Estatı´stica (http://www.datasus.gov.br).2.2. Statistical analysis
Analyses included examination of the number of new cases,
age-adjusted incidence rates (AAIRs), and age-speciﬁc incidence
rates (ASIRs) by each PBCR. AAIRs according to lymphoma subtype
(HL, NHL, and BL), gender, and time period were calculated with a
direct method using the proposed world population by age groups
of less than 19 years. For ASIRs according to lymphoma subtypes,
gender and time period were calculated by age and age group: <1,
1–4, 5–9, 10–14, and 15–19 years. In the 14 Brazilian PBCRs
coverage was limited to the capital city, so it was not possible to
obtain an arithmetic average for the entire country. The distribu-
tion of lymphoma incidence rates by PBCR was used to obtain the
median parameter. Thus, the incidence rates were orderly. The
median represented the value referent to 50% of the accumulated
distribution. The median was used to measure central tendency in
order to obtain an overall assessment of incidence rates (AAIR and
ASIR). Median ASIR was calculated by lymphoma subtype, gender,
and age group.
The social exclusion index (SEI) was built on the basis of three
dimensions: suitable life conditions, knowledge, and youth
vulnerability. The ﬁrst dimension includes a poverty indicator
(percentage of family heads with insufﬁcient income in each city),
an employment indicator (percentage of individuals aged >10
years working legally), and an inequality indicator (percentage of
family heads with a monthly income in US dollars >$1000 and
1000. The second comprises two indicators: literacy (percentage
of the population aged 5 years that is able to read and to write)
and years of study (mean number of years of study for family head),
and the last dimension includes a youth indicator (percentage of
the population aged 19 years) and a violence indicator
(homicides rate per 100,000 habitants). The SEI – which is a
synthesis of all three dimensions of social exclusion – was obtained
through the sum of the seven partial scores, which were weighted
as follows: poverty (17.0), employment (17.0), literacy (5.7),
education (11.3), youth (17.0), and violence (15.0) [10].
Cities were classiﬁed according to SEI with scores ranging from 0
(minimum) to 1 (maximum), where a higher SEI score indicates
better socioeconomic status. Correlations between SEI and incidence
rates were investigated using Spearman’s test. Wilcoxon’s test was
Table 1
Age-adjusted incidence rates for lymphomas in Brazilian PBCR, by gender according to lymphomas subtype.
Regions PBCR (period) n Ratio M/F HLa NHL#b BLc Total
lymphomasd
M F Total M F Total M F Total M F Total
North Manaus (2000–2004) 73 1.61 11.04 7.62 9.29 13.70 4.73 9.15 1.94 4.11 3.05 26.69 16.46 21.49
Northeast Aracaju (2000–2004) 22 1.75 5.35 7.18 6.28 15.39 8.33 11.85 9.43 0.00 4.77 30.17 15.51 22.90
Fortaleza (2001–2005) 101 1.35 11.73 11.36 11.51 10.76 5.48 8.13 3.17 1.12 2.16 25.66 17.96 21.80
Natal (2000–2004) 22 1.75 8.07 2.59 5.32 4.41 8.37 6.42 7.99 0.00 4.06 20.46 10.96 15.80
Recife (2000–2003) 41 1.05 7.97 11.06 9.58 7.43 4.63 6.02 3.32 2.56 2.90 18.72 18.25 18.50
Salvador (2000–2004) 69 1.65 6.59 4.89 5.72 9.10 4.51 6.79 0.46 0.48 0.47 16.15 9.88 12.98
Joa˜o Pessoa (2001–2005) 35 1.92 11.53 8.73 10.14 24.27 9.26 16.83 3.08 1.44 2.25 38.87 19.43 29.21
Middle-West Campo Grande (2000–2002) 23 4.75 14.38 4.18 9.37 26.63 3.33 15.09 5.34 3.33 4.33 46.35 10.85 28.79
Cuiaba´ (2001–2005) 35 2.18 10.98 4.92 7.97 17.92 9.75 13.82 1.69 0.00 0.86 30.59 14.67 22.66
Goiaˆnia (2001–2005) 54 2.00 17.49 6.83 12.26 10.37 6.22 8.30 6.21 1.75 4.03 34.08 14.81 24.59
Southeast Belo Horizonte (2000–2003) 84 2.11 17.64 8.27 12.97 12.73 4.55 8.64 3.30 2.26 2.78 33.67 15.08 24.39
Sa˜o Paulo (2001–2005) 668 1.73 17.00 10.76 13.89 21.40 11.97 16.69 5.62 2.18 3.92 44.02 24.91 34.50
South Curitiba (2001–2005) 73 1.52 16.56 9.20 12.92 6.52 7.21 6.84 4.08 1.37 2.75 27.16 17.79 22.51
Porto Alegre (2000–2004) 60 1.50 14.83 7.76 11.32 12.32 9.26 10.79 2.06 4.28 3.15 29.22 21.30 25.27
Median 57 1.74 11.63 7.69 9.86 12.52 6.71 8.89 3.31 1.59 2.97 29.69 15.98 22.78
Abbreviations: PBCR, population-based cancer registry; HL, Hodgkin lymphomas; NHL, non-Hodgkin lymphomas#; BL, Burkitt lymphoma; n, total number of cases include
HL, NHL#, BL; M, male; F, female; # non-Hodgkin lymphomas (II.b, 79%), that includes miscellaneous lymphoreticular neoplasms (II.d, 4%), unspeciﬁed lymphomas (II.e, 17%),
but Burkitt lymphoma; differences between gender.
a HL, p = 0.0035 (Wilcoxon test).
b NHL, p = 0.0024.
c BL, p = 0.0067.
d Total lymphomas, p = 0.0000 (t-test).
J.M.O. Ferreira et al. / Cancer Epidemiology 36 (2012) e221–e226 e223applied to test the differences between gender/age and lymphoma
subtypes; 95% conﬁdence intervals (CIs) were calculated using the
Poisson approximation, or exactly when less than 30 cases were
observed.
3. Results
The catchment area covered and time-points of data collection
for all 14 PBCRs represented 14% of the total Brazilian population
restricted to the main metropolitan areas; it was not possible to
obtain an arithmetic average for the entire country because these
PBCRs cover only the capital city. The period analyzed was from
2000 to 2005, and collected data were obtained consecutively for
at least 3 years in the ﬁve different geographical regions. AAIRs in
both genders of all cases of lymphoma in the 14 PBCRs varied from
12.9 to 34.5 per million, being lower in Salvador (12.9, CI 95% 9.86–
16.10) and higher in Sa˜o Paulo (34.5, CI 95% 31.85–37.14), Joa˜o
Pessoa (29.2 CI 95% 19.31–39.12), Campo Grande (28.8, CI 95%
16.81–40.76), and Porto Alegre (25.3, CI 95% 18.77–31.77). The
AAIR was higher in males (M:F ratio of 1.35:4.75) with the
exception of one city, where gender was equally distributed.
Median AAIR was 22.7 per million for all lymphomas, 9.8 per
million for HL, 8.8 per million for NHL, and 2.9 per million for BL
(Table 1 and Supplementary Table 1). The percentage ratio
distribution of the main lymphoma subtypes is shown in Fig. 1.
HL was the most common subtype in seven PBCRs (43–59%),
whereas NHL was the most common in seven PBCRs including
Natal (41%) to Cuiaba´ (60%). BL represented 3% in Salvador and
Cuiaba´ and 23% in Natal.
The AAIRs observed for HL ranged from 2.5 to 11.3 per
million for females and 5.3 to 17.6 per million for males; for
females, the highest AAIR was present in Fortaleza (11.36, CI 95%
7.10–15.61) and the lowest was found in Natal (2.5, CI 95% 1.05–
6.22). For males the highest AAIR was found in Belo Horizonte
(17.6, CI 95% 11.38–23.90) and the lowest in Aracaju (5.3, CI 95%
0.71–11.4). The AAIRs observed for NHL in females ranged from
3.3 per million (CI 95% 3.20–9.86) in Campo Grande to 11.9
per million (CI 95% 9.74–14.20) in Sa˜o Paulo, and for males from
4.4 per million in Natal to 26.6 per million in Campo Grande
(Table 1).HL had the highest median ASIR in both genders in the age
group 15–19 years (18.5 per million, Table 2). NHL show the
highest ASIR at two peaks: 11.1 per million (1–4 years of age) and
13.2 per million (15–19 years of age). For BL the ASIR decreased
with age, being 4.7 per million at 1–4 years of age and 3.6 per
million at 5–9 years of age. Higher median ASIRs were observed for
males with HL in age groups 1–14 years; ASIR was similar between
genders for the age group 15–19 years. Median ASIR for NHL was
higher for males in all age groups. Median ASIR for BL was higher
among age group 1–4 years (4.7/million) and in males (5.3/million)
(Table 2).
The SEIs measured from different Brazilian regions varied
from 0.52 to 0.76. The lowest SEI was observed in the city of
Fortaleza and Manaus located in the north region (0.52) and the
highest SEI was observed in Porto Alegre (0.76) in South Brazil
(Supplementary Figs. 1 and 2). The correlation between SEI and
lymphoma subtypes was of borderline signiﬁcance for HL
(P = 0.06) but not for NHL (P = 0.53) or BL (P = 0.60) (Fig. 2A, B,
and C, respectively). The differences in the incidence rates of HL
correlating borderline with SEI were observed in different
geographic regions (Fig. 2A). HL incidence was higher in the
south, south-east, and middle-west, where the SEI varied from
0.59 to 0.76; the opposite was observed in the North and North-
east regions (SEI 0.52–0.59).
4. Discussion
As a whole, the NHL age-speciﬁc patterns found in Brazil are
similar to those described in developed countries. For instance, in
the surveillance, epidemiology, and end results database 2003–
2007, the National Cancer Institute in the USA reported an NHL
AAIR of 8.5 per million [11]. The demographic characteristics of
developed countries were similar to those we observed in Brazil,
with males more prevalent among observed cases of NHL. Data
from the International Agency for Research on Cancer showed that
lymphoid malignancies are generally more common in males than
females, with differences tending to be slightly more pronounced
in less developed regions of the world. Regarding ages for NHL, the
greatest ASIR was found at two peaks: at 1–4 years of age and at
15–19 years of age. For HL, ASIR rates increase with increasing age;
Table 2
Age-speciﬁc incidence rates for lymphomas in Brazilian PBCR, by gender according to lymphomas subtype.
Regions PBCR (period)
Gender 1–4 5–9 10–14 15–19
HL NHL# BL HL NHL# BL HL NHL# BL HL NHL# BL
North Manaus (2000–2004) M 2.80 19.57 5.59 14.45 7.23 2.41 15.66 10.44 0.00 14.37 21.56 0.00
F 0.00 0.00 2.87 12.30 12.30 2.46 17.96 5.13 10.27 2.22 2.22 2.22
T 1.42 9.91 4.25 13.39 9.74 2.43 16.82 7.76 5.18 8.06 11.52 1.15
Northeast Aracaju (2000–2004) M 0.00 34.67 11.56 0.00 0.00 19.00 8.50 8.50 8.50 15.28 22.91 0.00
F 0.00 0.00 0.00 9.68 19.36 0.00 0.00 8.45 0.00 21.16 7.05 0.00
T 0.00 17.70 5.90 4.79 9.59 9.59 4.24 8.47 4.24 18.34 14.67 0.00
Fortaleza (2001–2005) M 11.34 15.87 11.34 5.42 7.23 1.81 13.84 8.65 0.00 20.17 11.77 0.00
F 4.67 4.67 4.67 13.05 7.46 0.00 17.20 3.44 0.00 13.79 7.66 0.00
T 8.05 10.35 8.05 9.17 7.34 0.92 15.53 6.04 0.00 16.84 9.62 0.00
Natal (2000–2004) M 7.45 0.00 14.90 5.88 17.64 17.64 16.29 0.00 0.00 5.09 0.00 0.00
F 0.00 15.43 0.00 6.05 0.00 0.00 0.00 15.98 0.00 4.78 4.78 0.00
T 3.79 7.58 7.58 5.96 8.95 8.95 8.07 8.07 0.00 4.93 2.46 0.00
Recife (2000–2003) M 0.00 5.11 0.00 15.94 11.96 3.99 7.38 7.38 0.00 10.33 6.89 0.00
F 0.00 10.67 10.67 4.14 8.28 0.00 11.21 0.00 0.00 33.35 0.00 0.00
T 0.00 7.83 5.22 10.15 10.15 2.03 9.29 3.71 0.00 22.03 3.39 5.08
Salvador (2000–2004) M 0.00 4.56 0.00 7.41 9.26 1.85 6.91 6.91 0.00 14.14 18.38 10.33
F 0.00 2.38 0.00 7.63 1.91 1.91 5.22 8.70 0.00 8.04 6.70 0.00
T 0.00 3.49 0.00 7.52 5.64 1.88 6.07 7.80 0.00 11.01 12.38 0.00
Joa˜o Pessoa (2001–2005) M 0.00 53.60 0.00 6.92 20.76 6.92 25.54 0.00 0.00 18.00 18.00 6.00
F 9.27 0.00 0.00 0.00 14.17 0.00 6.41 0.00 6.41 22.49 5.62 0.00
T 4.55 27.29 0.00 3.50 17.51 3.50 15.99 0.00 3.20 20.32 11.61 2.90
Middle-West Campo Grande (2000–2002) M 13.39 26.78 13.39 10.12 20.24 0.00 19.45 38.91 0.00 18.93 28.39 9.46
F 0.00 13.88 13.88 0.00 0.00 0.00 0.00 0.00 0.00 18.60 0.00 0.00
T 6.81 20.44 13.63 5.13 10.26 0.00 9.90 19.80 0.00 18.76 14.07 4.69
Cuiaba´ (2001–2005) M 7.06 21.17 7.06 10.76 16.14 0.00 9.98 14.97 0.00 19.32 24.15 0.00
F 7.29 14.59 0.00 0.00 0.00 0.00 0.00 10.18 0.00 14.09 9.39 0.00
T 7.17 17.93 3.59 5.46 8.19 0.00 5.04 12.60 0.00 16.67 16.67 0.00
Goiaˆnia (2001–2005) M 5.13 15.40 5.13 28.82 8.23 16.47 26.91 3.84 3.84 13.35 16.69 0.00
F 0.00 10.62 0.00 4.22 0.00 4.22 3.89 3.89 0.00 21.78 12.45 3.11
T 2.61 13.05 2.61 16.67 4.17 10.42 15.46 3.86 1.93 17.71 14.49 1.61
Southeast Belo Horizonte (2000–2003) M 0.00 13.59 3.40 16.72 5.57 5.57 25.80 15.48 2.58 34.02 20.41 2.27
F 3.50 0.00 3.50 0.00 5.68 5.68 2.60 5.21 0.00 30.43 8.70 0.00
T 1.72 6.90 3.45 8.44 5.63 5.63 14.26 10.37 1.30 32.19 14.43 1.11
Sa˜o Paulo (2001–2005) M 3.28 14.20 11.47 18.63 23.28 5.59 18.45 18.88 3.95 32.90 32.90 2.01
F 2.26 12.97 5.07 7.17 10.52 1.91 9.28 8.40 1.77 28.15 19.28 0.39
T 2.77 13.59 8.32 12.98 16.99 3.77 13.88 13.66 2.86 30.48 25.96 1.18
South Curitiba (2001–2005) M 3.59 0.00 0.00 17.04 0.00 11.36 11.02 16.53 5.51 39.81 12.44 0.00
F 0.00 3.75 0.00 0.00 8.88 2.96 14.05 8.43 2.81 26.86 9.77 0.00
T 1.83 1.83 0.00 8.69 4.35 7.25 12.52 12.52 4.17 33.28 11.09 0.00
Porto Alegre (2000–2004) M 4.66 9.31 4.66 11.34 11.34 3.78 10.79 7.19 0.00 37.57 25.05 0.00
F 0.00 14.52 9.68 0.00 7.83 7.83 18.69 7.48 0.00 15.79 9.47 0.00
T 2.37 11.86 7.12 5.77 9.62 5.77 14.67 7.33 0.00 26.72 17.29 0.00
Median M 3.44 14.80 5.36 11.05 10.30 4,78 14.75 8.58 0.00 18.47 19.40 0.00
F 0.00 7.65 1.44 4.18 7.65 0.96 5.82 6.35 0.00 19.88 7.36 0.00
T 2.49 11.11 4.74 7.98 9.27 3.64 13.20 7.64 0.65 18.55 13.23 0.56
Abbreviations: PBCR, population-based cancer registry; HL, Hodgkin lymphomas; NHL#, non-Hodgkin lymphomas#; BL, Burkitt lymphoma; n, total number of cases include
HL, NHL#, BL; M, male; F, female; T: total.
#Non-Hodgkin lymphomas (II.b, 79%), that includes miscellaneous lymphoreticular neoplasms (II.d, 4%), unspeciﬁed lymphomas (II.e, 17%), but Burkitt lymphoma.
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aged 15–19 years of age [12].
The interpretation of the highest AAIRs for NHL found in Sa˜o
Paulo and Joa˜o Pessoa compared with the lowest observed. Recife
and Natal may reﬂect the better opportunities for diagnosis in
some regions and, in contrast, greater rates of misdiagnosis and
under-diagnosis in resource-poor regions of the country. It is well
known that the broad anatomy-based categories of NHL require
modern laboratory facilities to classify lymphoid malignancies
appropriately. Even considering these pitfalls, the median AAIR for
total lymphomas was 22.6 per million, similar to the SEER data of
23.8 per million in the United States [1].
It has been demonstrated that childhood HL displays charac-
teristic epidemiological, clinical, and pathological features accord-
ing to various geographic areas, particularly according to the
socioeconomic level of a given country [13]. HL incidence
distribution has two peaks – one in adolescents/young adults
and one in the elderly – which comprise distinct disease entities
[14–19]. Recently, three Brazilian studies suggested that theepidemiological patterns are not strictly segregated, and that
overlap may exist among the described forms of the disease.
Gualco et al. reported on 476 cases of classical HL ascertained from
all Brazilian geographic regions. NS was found to be the most
frequent subtype (76.9%) in all age groups [20]. Similarly, Barros
et al. reported data from a single center located in the Brazilian
south-east region where the authors did not observe an early
childhood peak of HL. The majority of cases occurred in children
over 10 years of age and were of the NS subtype; Epstein–Barr virus
(EBV) was identiﬁed in 44.8% of cases, without preferential
association with age (<10 years versus >10 years); EBV positivity
was more prevalent in MC cases [21]. The third study was
performed in the north-east region, and in contrast to previously
reported data found EBV-associated HL disease to be the most
common (87%) with a high frequency of the MC subtype [22].
In agreement with these data, our analyses of 14 PBCRs showed
increasing median ASIR with age, most notable in south-east and
south PBCRs. Higher SEI was borderline correlated with higher
incidences of HL (P = 0.06) occurring in more developed Brazilian
Fig. 2. The incidence rates of lymphoma subtypes and correlation with social exclusion index in different Brazilian regions.
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evidence of any signiﬁcant trends for lymphoma subtypes, or for
Hodgkin lymphoma at younger ages [23]. In addition, a Canadian
study explored the relationship between socioeconomic status,
neighborhood income, and the incidence of childhood solid tumors
and lymphomas. In this study no consistent relationship between
socioeconomic status and lymphoma was found, suggesting an
overall pattern compatible with random variability [24].
BL is a highly proliferative B-cell tumor ﬁrst described in African
children more than ﬁve decades ago by Dennis Burkitt as being EBV
associated [25]. Within the cancer registries available in Africa, the
incidence of endemic BL (eBL) is highest in the cancer registry from
the Kyadondo County, Uganda, with an AAIR of 4.7 per 100,000 for
boys and 3.0 per 100,000 for girls [6]. In recent years the incidence
of BL has increased in the endemic areas of Africa, overlapping with
the epidemic of HIV and malaria in the region. In Uganda, BL
incidence rates have reportedly increased from 9.5 per 106 in
1960–1971 to 34.3 per 106 for the period 1991–1997 [26].
Sporadic BL (sBL) is the form described outside of African endemic
regions and is the third most common lymphoid malignancy
among children less than 15 years old in the United States, after
acute lymphoblastic leukemia (ALL) and HL [1].
Whereas eBL is linked to EBV and malaria, this factor appears to
be less important in sBL where EBV DNA is integrated or clonally
detected in only 20–30% of tumors [27,28]. Previous studies on BL
in Brazil demonstrated intermediate features between endemic
and sporadic cases regarding EBV–tumor association and clinical
disease presentation [29–32]. However, the incidence rates of BL in
different regions of Brazil have been unknown until now. This is
the ﬁrst report of Brazilian childhood BL incidence which includes
analysis of all ﬁve geographic regions. Despite some discrepant
variation in the AAIR found among the 14 PBCRs (0.47 per million
in Salvador up to 4.77 per million in Aracaju), the median AAIR was
2.97 per million, which is comparable to the ASIR of sBL in theUnited States for the period 2003–2007 (2.4 per million person-
years, 0–19 years) [11]. One possible explanation for the lower
incidence rate of BL observed in Salvador could be related to
unreported cases, as previously reported in the same PBCR for ALL
[33,34].
Regarding median ASIR of BL in the 14 PBCRs, the incidence
rates for both age groups (4.74 per million for 1–4 years and 3.64
per million for 5–9 years) were similar, and then declined with
increasing age. Overall, BL predominated among boys in both age
groups (1–4 and 5–9 years). Mbulaiteye et al. recently reported an
age peak incidence for BL similar to that in the present report [35].
Socioeconomic status has been proposed to modulate EBV
infection and the risk of EBV-associated lymphomas [36]. In fact,
poverty lowers the age of initial EBV infection, and early exposure
to EBV could be a trigger for BL development [31,37,38].
Furthermore, socioeconomic status may also be a surrogate
marker for the presence of factors associated with a poor defense
response toward environmental exposure to infection and chronic
malnutrition [39].
To summarize, we describe for the ﬁrst time the incidence rates
of childhood lymphomas in Brazil. Our ﬁndings may be useful for
prioritizing cancer registry quality and supporting additional
research on risk factors for childhood lymphomas.
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